Martin Pepeljugoski

• Represented Bain Capital in its investment in InnovaCare Health.
• Represented Prospect Hill Growth Partners in its sale of a significant minority investment in its portfolio company Walker Edison Furniture Company to Blackstone Tactical Opportunities.
• Represented THL in its sale of U.S. Nursing Corporation and Fastaff Travel Nursing to Cornell Capital and Trilantic North America.
• Represented Bain Capital in the combination of its portfolio company Cerevel Therapeutics with ARYA Sciences Acquisition Corp II, a special purpose acquisition company.
• Represented Summit Partners and Silversmith Capital Partners in their sale of LifeStanceHealth to TPG.
• Represented THL in its investment in Intelligent Medical Objects.
• Represented ORIX Capital Partners in its sale of RoadSafe Travel Systems, Inc. to Investcorp and Trilantic North America.
• Represented Bain Capital in its investment in Zelis Healthcare and RedCard Systems.
• Represented a private equity firm in its bid to acquire a privately-held global eyewear and eyecare company.
• Represented a private equity firm in its bid to acquire a privately-held national provider of rehabilitation mobility, seating and positioning solutions.
• Represented a private equity firm in its bid to acquire a privately-held national wealth management firm.
• Represented a private equity firm in its bid to acquire a privately-held regional provider of fire detection, suppression and protection solutions.
• Represented a private equity firm in its bid to acquire a privately-held global provider of flavor bases used in the animal pharmaceutical industry.
• Represented a private equity firm in its bid to acquire a privately-held national provider of analytics and technology-enabled services to healthcare programs and hospitals.

Martin’s matters prior to joining Ropes & Gray include:

• Represented GKN in its defense against a £8.1 billion unsolicited takeover offer by Melrose and the proposed $6.1 billion combination of its driveline business with Dana.  The proposed combination consisted of an internal reorganization of GKN, a spin-off GKN’s driveline business to a new publicly-traded UK company and a merger between the UK company and Dana resulting in a corporate inversion of Dana. 
• Represented Brunswick in the $490 million sale of its fitness and recreational businesses to KPS Capital as well as the proposed separation and spin-off of the businesses into a new publicly-traded company prior to their sale
• Represented Cincinnati Bell in the $650 million cash/stock election acquisition of Hawaiian Telcom
• Represented Cincinnati Bell in connection with its $200 million acquisition of OnX Enterprise Solutions
• Represented a publicly-traded company in its bid to acquire a privately-held North American chocolate company
• Represented a publicly-traded company in its bid to acquire a privately-held marine steering and control systems company
• Represented Atlas Air in connection with its grant of new warrants to, and entry into a commercial services agreement with, Amazon
• Represented a privately-held revenue cycle management company in connection with its sale
• Represented a publicly-traded company in its bid to acquire a privately-held payment processing company
• Represented a privately-held pharmaceutical distribution company in connection with its sale
• Represented a privately-held medical device company involved in litigation with an investor in connection with the company’s exploration of transaction structures and corporate strategies enabling the company’s sale to a publicly-traded company in light of the litigation
• Represented Cable One in connection with its acquisition of Clearwave Communications
• Represented Cincinnati Bell in connection with its successful proxy contest against GAMCO
• Represented Conduent in connection with its settlement of certain matters with Darwin Deason, one of its largest stockholders
• Represented Moelis in connection with its fairness advisory to Tribune Media Company in connection with its acquisition by Nexstar
• Represented a “bulge bracket” financial institution in connection with its fairness advisory to KLX in connection with the sale of its aerospace business to Boeing
• Represented Scientific Games in its “Up-C” initial public offering of its social gaming business
• Represented Mylan in connection with the financing of its acquisition of Meda.  The $6.5 billion financing consisted of four series of unsecured debt securities.
• Represented Mylan in connection with concurrent A/B exchange offers for two separate offerings of its unsecured debt securities. 
• Represented Mylan in connection with its €3 billion fixed and floating rate Euro-denominated offering of unsecured debt securities
• Represented Mylan in connection with its €500 million floating rate Euro-denominated offering of unsecured debt securities
• Represented Wells Fargo in connection with Zimmer Biomet’s $1.1 billion debt tender offer for five series of its unsecured debt securities
• Represented BNP Paribas in connection with Zimmer Biomet’s €1 billion fixed rate Euro-denominated offering of unsecured debt securities
• Represented a “bulge bracket” financial institution in connection with U.S. Concrete’s $400 million offering of unsecured debt securities
• Represented a “bulge bracket” financial institution in connection with US Concrete’s $200 million fungible tack-on offering of unsecured debt securities
• Represented a “bulge bracket” financial institution in connection with the $1.1 billion “bought” secondary offering of Zimmer Biomet’s common stock and Zimmer Biomet’s concurrent repurchase of $250 million of its common stock
• Represented two “bulge bracket” financial institutions in connection with the $1.3 billion “bought” secondary offering of Zimmer Biomet’s common stock
• Represented two “bulge bracket” financial institutions in connection with the $960 million “bought” secondary offering of Zimmer Biomet’s common stock
• Represented Evolent in connection with the $170 million “bought” secondary offering of its common stock
• Represented Evolent in connection with the $150 million secondary offering and the optioned $25 million secondary offering of its common stock
• Represented Credit Suisse in connection with the cash flow financing of Canadian Pension Plan Investment Board’s acquisition of Antares Capital and its loan portfolio. The financing consisted of a $1.2 billion secured term loan credit facility, $2.0 billion secured revolving credit facility and $3.0 billion secured asset-based lending credit facility.
• Represented a “bulge bracket” financial institution in connection with the cash flow financing of Bain Capital’s cross-border acquisition of TI Automotive. The financing consisted of a $1.3 billion secured term loan credit facility, $125 million secured revolving credit facility and $100 million secured asset-based lending credit facility.
• Represented a “bulge bracket” financial institution in connection with TI Automotive’s $100 million fungible tack-on incremental financing
• Represented a “bulge bracket” financial institution in connection with the acquisition financing of Team Health’s acquisition of IPC Healthcare
• Represented a “bulge bracket” financial institution in connection with the $1.25 billion amendment and restatement of Team Health’s secured term loan and revolving credit facilities
• Represented BDT Capital Partners in connection with the financing of its acquisition of Marquette Transportation Company. The financing consisted of a $400 million secured asset-based lending credit facility and $250 million unsecured debt securities.
• Represented a “bulge bracket” financial institution in connection with an amendment to L Brands’ secured $1 billion revolving credit facility
• Represented Crown Castle in connection three incremental unsecured revolving credit facilities totaling $830 million
• Represented three European “bulge bracket” financial institutions in connection with the secured acquisition financing of a private equity firm’s bid to acquire Ista Group
• Represented a “bulge bracket” financial institution in connection with the secured acquisition financing of a private equity firm’s bid to acquire PetCo
• Represented a “bulge bracket” financial institution in connection with the secured acquisition financing of a private equity firm’s bid to acquire Atotech
• Represented a “bulge bracket” financial institution in connection with the secured financing of a private equity firm’s bid to acquire the post-harvest specialty chemical business of Dow Chemical